The present invention is directed to methods of inhibiting a tauopathy in a patient by administration of a compound of formula I:
Novel aminothienopyridazine compounds are also described.
本发明涉及通过给予I型化合物来抑制患者的tau病变的方法:还描述了新的氨基噻吩吡嗪化合物。
MAHESH V. K.; GOYAL R. N.; GUPTA RAMA; SHARMA RAKESH, J. INDIAN CHEM. SOC., 1980, 57, NO 10, 1037-1038
作者:MAHESH V. K.、 GOYAL R. N.、 GUPTA RAMA、 SHARMA RAKESH
DOI:——
日期:——
PATEL, HIMATKUMAR V.;FERNANDES, P. S., INDIAN. J. CHEM. B , 28,(1989) N, C. 733-744
作者:PATEL, HIMATKUMAR V.、FERNANDES, P. S.
DOI:——
日期:——
SMITH, HERMAN W.
作者:SMITH, HERMAN W.
DOI:——
日期:——
EL-KERDAWY, M. M.;ISMAIEL, A. M.;YOUSIF, M. Y.;EL-SHERBENY, M. A., PAKISTAN J. SCI. AND IND. RES., 32,(1989) N, C. 510-512
作者:EL-KERDAWY, M. M.、ISMAIEL, A. M.、YOUSIF, M. Y.、EL-SHERBENY, M. A.